ELIGARD
22,5MG INJ PSO LQF 1+1
Announcement of launch, break or close-out of marketing of a medicinal product
| Type of announcement | Effective date | Alternate medicines ? | Reason for interruption/cessation of marketing | Estimated renewal date |
|---|---|---|---|---|
| Resumption of marketing | 08.03.2022 | |||
| Interruption of marketing | 28.01.2022 |
0197427, 0252456, 0253124 Lék v jiné síle/lékové formě (dle uvážení lékaře) |
Manufacturing reasons | 03/2022 |
All reports are available in the Overview.
cz